Compare ELAN & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | QXO |
|---|---|---|
| Founded | 1954 | 1988 |
| Country | United States | United States |
| Employees | N/A | 7794 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 16.3B |
| IPO Year | 2018 | N/A |
| Metric | ELAN | QXO |
|---|---|---|
| Price | $22.16 | $19.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 14 |
| Target Price | $27.89 | ★ $32.85 |
| AVG Volume (30 Days) | 3.9M | ★ 14.0M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,715,000,000.00 | N/A |
| Revenue This Year | $8.21 | $70.27 |
| Revenue Next Year | $5.31 | $38.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $9.32 | $12.76 |
| 52 Week High | $27.72 | $27.61 |
| Indicator | ELAN | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 39.98 | 41.33 |
| Support Level | $20.73 | $18.48 |
| Resistance Level | $23.16 | $20.54 |
| Average True Range (ATR) | 0.86 | 1.19 |
| MACD | -0.10 | -0.23 |
| Stochastic Oscillator | 14.82 | 1.77 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.